JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more
About this episode
This episode discusses recent articles from JAMA, including insulin cost caps for Medicare beneficiaries and new treatments for obesity and diabetes.
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Linda Brubaker, MD, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from June 6-12, 2026. Related Content: Audio Highlights
More episodes of JAMA Editors' Summary
- Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment, YEARS Algorithm for Diagnosis of PE in Patients With Cancer, HPV Screening and Self-Collected Vaginal Samples, and more
- Online Prescribing of GLP-1 Receptor Agonists, Alcohol-Related Liver Disease, Survival After Lung Transplant for Select Lung Cancer Patients, and More
- Social Media Use by Adults for Health Information, Social Media Use in Children, Managing Familial Hypercholesterolemia, and more
- Trends in Patient Portal Messaging, Cognitive Behavioral Therapy for Chronic Pain, End-of-Life Care for People Who Are Incarcerated, and more
- AI-Based OCT Systems to Detect Diabetic Macular Edema, Low Back Pain Review, Healthy Dialogue on Early-Onset Cancer, and more
- Cancer Diagnostic Delay Rates and Multicancer Early Detection Test, Cost-Effectiveness of FIT Testing With H Pylori Stool Antigen, JAMA at ERA, and more
Explore listener stats, chart rankings, contacts and more on the JAMA Editors' Summary podcast page.